195 related articles for article (PubMed ID: 32903706)
1. Antimicrobial Peptide Reverses ABCB1-Mediated Chemotherapeutic Drug Resistance.
Luo X; Teng QX; Dong JY; Yang DH; Wang M; Dessie W; Qin JJ; Lei ZN; Wang JQ; Qin Z; Chen ZS
Front Pharmacol; 2020; 11():1208. PubMed ID: 32903706
[TBL] [Abstract][Full Text] [Related]
2. Reversal effect of FW-04-806, a macrolide dilactone compound, on multidrug resistance mediated by ABCB1 and ABCG2 in vitro and in vivo.
Zhang Z; Ma C; Li P; Wu M; Ye S; Fu L; Xu J
Cell Commun Signal; 2019 Sep; 17(1):110. PubMed ID: 31472682
[TBL] [Abstract][Full Text] [Related]
3. The Multidrug Resistance-Reversing Activity of a Novel Antimicrobial Peptide.
Teng QX; Luo X; Lei ZN; Wang JQ; Wurpel J; Qin Z; Yang DH
Cancers (Basel); 2020 Jul; 12(7):. PubMed ID: 32707710
[TBL] [Abstract][Full Text] [Related]
4. Midostaurin Reverses ABCB1-Mediated Multidrug Resistance, an
Ji N; Yang Y; Cai CY; Wang JQ; Lei ZN; Wu ZX; Cui Q; Yang DH; Chen ZS; Kong D
Front Oncol; 2019; 9():514. PubMed ID: 31275850
[TBL] [Abstract][Full Text] [Related]
5. Adagrasib, a KRAS G12C inhibitor, reverses the multidrug resistance mediated by ABCB1 in vitro and in vivo.
Zhang Y; Li C; Xia C; Wah To KK; Guo Z; Ren C; Wen L; Wang F; Fu L; Liao N
Cell Commun Signal; 2022 Sep; 20(1):142. PubMed ID: 36104708
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of ABCB1 Transporter Confers Resistance to mTOR Inhibitor WYE-354 in Cancer Cells.
Wang J; Yang DH; Yang Y; Wang JQ; Cai CY; Lei ZN; Teng QX; Wu ZX; Zhao L; Chen ZS
Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32092870
[TBL] [Abstract][Full Text] [Related]
7. Lansoprazole (LPZ) reverses multidrug resistance (MDR) in cancer through impeding ATP-binding cassette (ABC) transporter-mediated chemotherapeutic drug efflux and lysosomal sequestration.
Ji N; Li H; Zhang Y; Li Y; Wang P; Chen X; Liu YN; Wang JQ; Yang Y; Chen ZS; Li Y; Wang R; Kong D
Drug Resist Updat; 2024 Jun; 76():101100. PubMed ID: 38885537
[TBL] [Abstract][Full Text] [Related]
8. Dacomitinib antagonizes multidrug resistance (MDR) in cancer cells by inhibiting the efflux activity of ABCB1 and ABCG2 transporters.
Fan YF; Zhang W; Zeng L; Lei ZN; Cai CY; Gupta P; Yang DH; Cui Q; Qin ZD; Chen ZS; Trombetta LD
Cancer Lett; 2018 May; 421():186-198. PubMed ID: 29331420
[TBL] [Abstract][Full Text] [Related]
9. Tetrandrine Interaction with ABCB1 Reverses Multidrug Resistance in Cancer Cells Through Competition with Anti-Cancer Drugs Followed by Downregulation of ABCB1 Expression.
Liao D; Zhang W; Gupta P; Lei ZN; Wang JQ; Cai CY; Vera AA; Zhang L; Chen ZS; Yang DH
Molecules; 2019 Nov; 24(23):. PubMed ID: 31801248
[TBL] [Abstract][Full Text] [Related]
10. Tepotinib reverses ABCB1-mediated multidrug resistance in cancer cells.
Wu ZX; Teng QX; Cai CY; Wang JQ; Lei ZN; Yang Y; Fan YF; Zhang JY; Li J; Chen ZS
Biochem Pharmacol; 2019 Aug; 166():120-127. PubMed ID: 31078601
[TBL] [Abstract][Full Text] [Related]
11. Crizotinib (PF-02341066) reverses multidrug resistance in cancer cells by inhibiting the function of P-glycoprotein.
Zhou WJ; Zhang X; Cheng C; Wang F; Wang XK; Liang YJ; To KK; Zhou W; Huang HB; Fu LW
Br J Pharmacol; 2012 Jul; 166(5):1669-83. PubMed ID: 22233293
[TBL] [Abstract][Full Text] [Related]
12. PD173074, a selective FGFR inhibitor, reverses ABCB1-mediated drug resistance in cancer cells.
Patel A; Tiwari AK; Chufan EE; Sodani K; Anreddy N; Singh S; Ambudkar SV; Stephani R; Chen ZS
Cancer Chemother Pharmacol; 2013 Jul; 72(1):189-99. PubMed ID: 23673445
[TBL] [Abstract][Full Text] [Related]
13. Lazertinib improves the efficacy of chemotherapeutic drugs in ABCB1 or ABCG2 overexpression cancer cells i
Fan Y; Tao T; Guo Z; Wah To KK; Chen D; Wu S; Yang C; Li J; Luo M; Wang F; Fu L
Mol Ther Oncolytics; 2022 Mar; 24():636-649. PubMed ID: 35284628
[TBL] [Abstract][Full Text] [Related]
14. CEP-33779 antagonizes ATP-binding cassette subfamily B member 1 mediated multidrug resistance by inhibiting its transport function.
Tang SJ; Chen LK; Wang F; Zhang YK; Huang ZC; To KK; Wang XK; Talele TT; Chen ZS; Chen WQ; Fu LW
Biochem Pharmacol; 2014 Sep; 91(2):144-56. PubMed ID: 25058526
[TBL] [Abstract][Full Text] [Related]
15. Erdafitinib Antagonizes ABCB1-Mediated Multidrug Resistance in Cancer Cells.
Feng W; Zhang M; Wu ZX; Wang JQ; Dong XD; Yang Y; Teng QX; Chen XY; Cui Q; Yang DH
Front Oncol; 2020; 10():955. PubMed ID: 32670878
[TBL] [Abstract][Full Text] [Related]
16. Sildenafil reverses ABCB1- and ABCG2-mediated chemotherapeutic drug resistance.
Shi Z; Tiwari AK; Shukla S; Robey RW; Singh S; Kim IW; Bates SE; Peng X; Abraham I; Ambudkar SV; Talele TT; Fu LW; Chen ZS
Cancer Res; 2011 Apr; 71(8):3029-41. PubMed ID: 21402712
[TBL] [Abstract][Full Text] [Related]
17. Regorafenib overcomes chemotherapeutic multidrug resistance mediated by ABCB1 transporter in colorectal cancer: In vitro and in vivo study.
Wang YJ; Zhang YK; Zhang GN; Al Rihani SB; Wei MN; Gupta P; Zhang XY; Shukla S; Ambudkar SV; Kaddoumi A; Shi Z; Chen ZS
Cancer Lett; 2017 Jun; 396():145-154. PubMed ID: 28302530
[TBL] [Abstract][Full Text] [Related]
18. The WD repeat-containing protein 5 (WDR5) antagonist WDR5-0103 restores the efficacy of cytotoxic drugs in multidrug-resistant cancer cells overexpressing ABCB1 or ABCG2.
Wu CP; Hsieh YJ; Tseng HY; Huang YH; Li YQ; Hung TH; Wang SP; Wu YS
Biomed Pharmacother; 2022 Oct; 154():113663. PubMed ID: 36081287
[TBL] [Abstract][Full Text] [Related]
19. NVP-CGM097, an HDM2 Inhibitor, Antagonizes ATP-Binding Cassette Subfamily B Member 1-Mediated Drug Resistance.
Zhang M; Chen XY; Dong XD; Wang JQ; Feng W; Teng QX; Cui Q; Li J; Li XQ; Chen ZS
Front Oncol; 2020; 10():1219. PubMed ID: 32793491
[TBL] [Abstract][Full Text] [Related]
20. Motesanib (AMG706), a potent multikinase inhibitor, antagonizes multidrug resistance by inhibiting the efflux activity of the ABCB1.
Wang YJ; Kathawala RJ; Zhang YK; Patel A; Kumar P; Shukla S; Fung KL; Ambudkar SV; Talele TT; Chen ZS
Biochem Pharmacol; 2014 Aug; 90(4):367-78. PubMed ID: 24937702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]